Acasti announces appointment of prashant kohli as ceo

Laval, qc , april 4, 2023 /prnewswire/ -- acasti pharma inc. ("acasti" or the "company") (nasdaq: acst), a late-stage specialty pharma company advancing drug candidates for rare and orphan diseases, today announced the appointment of prashant kohli as acasti's new chief executive officer, succeeding jan d'alvise. the parties have mutually agreed to part ways, and ms.
ACST Ratings Summary
ACST Quant Ranking